General research on TNF inhibitors
- Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange. van Schie et al., Sci Rep. 2016 Sep 8;6:32747.
- Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations. van Bezooijen et al., Ther Drug Monit. 2016 Aug;38(4):432-8. doi: 10.1097/FTD.0000000000000310. PMID: 27120178.
- The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region. van Schie et al., Ann Rheum Dis 2015; 74(1):311-4
- Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity. van Schie et al., MAbs. 2015;7(4):662-71.
- Drug interference in immunogenicity assays depends on valency. Rispens et al., J Pharm Biomed Anal 2013; 85C:179-185.
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. van Schouwenburg et al., Nat Rev Rheumatol 2013; 9(3):164-72. Epub 2013 Feb 12. Review.
